# Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED

> **NCT05422001** · PHASE4 · TERMINATED · sponsor: **University of Aarhus** · enrollment: 116 (actual)

## Conditions studied

- Acute Pain
- Opioid Use

## Interventions

- **DRUG:** low dose ketamine
- **DRUG:** Placebo (saline)

## Key facts

- **NCT ID:** NCT05422001
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-31
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-08-15
- **Target enrollment:** 116 (ACTUAL)
- **Why stopped:** Not able to recruit opioid tolerant patients as expected
- **Last updated:** 2023-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05422001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05422001, "Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05422001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*